Signal: CAR-T study suggests cell therapy can treat autoimmune diseases December 11, 2023 No Comments
Verigraft reaches 50% recruitment in personalised vein transplant trial December 11, 2023 No Comments
Establishment Labs sees highest filings and grants during July in Q3 2023 December 11, 2023 No Comments